Expression of CD33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia
Journal article published in 2017 by
Naeem Khan,
Robert Hills,
P. Virgo,
Steven Knapper,
David Grimwade,
N. H. Russell,
Burnett Ak,
Sylvie Freeman 
